Cita APA (7a ed.)
Vikse, J., Rygh, A., Kaisen, K., & Omdal, R. (2017). Life-threatening rituximab-induced pyoderma gangrenosum successfully treated with intravenous immunoglobulin. Scandinavian Journal of Rheumatology, 46(5), 413-415.
Cita Chicago Style (17a ed.)
Vikse, J., A. Rygh, K. Kaisen, y R. Omdal. "Life-threatening Rituximab-induced Pyoderma Gangrenosum Successfully Treated with Intravenous Immunoglobulin." Scandinavian Journal of Rheumatology 46, no. 5 (2017): 413-415.
Cita MLA (9a ed.)
Vikse, J., et al. "Life-threatening Rituximab-induced Pyoderma Gangrenosum Successfully Treated with Intravenous Immunoglobulin." Scandinavian Journal of Rheumatology, vol. 46, no. 5, 2017, pp. 413-415.
Precaución: Estas citas no son 100% exactas.